Gilead Sciences Inc's remdesivir had little or no effect on COVID-19 patients' length of hospital stay or chances of survival, a clinical trial by the World Health Organization (WHO) has found.
from NDTV News - World-news https://ift.tt/3nX8fwP
Last Known Survivor Of Amazon Tribe, Who Evaded Contact, Dies
-
For more than 20 years he lived alone in the Brazilian Amazon eating nuts,
fruit and game -- a symbol of the struggle of indigenous people who exist
in iso...
3 years ago
0 Comments:
Post a Comment